AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks

PowerShares Dynamic Pharmaceuticals ETF News

$80.70
-0.111 (-0.137%)
At Close: May 21, 2024

Pharma ETFs in Focus Post Q2 Earnings

01:47pm, Friday, 11'th Aug 2023
Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.

5 Sector ETF Winners Amid Q2 Earnings Season

10:01am, Thursday, 10'th Aug 2023
It has been almost a month since the second-quarter earnings season kicked off. These sectors emerged winners so far in this earnings season.
If you're interested in broad exposure to the Healthcare - Pharma segment of the equity market, look no further than the Invesco Dynamic Pharmaceuticals ETF (PJP), a passively managed exchange traded
55 percent of Invesco Dynamic Pharmaceuticals ETF's investment is in ten giant-capitalized and large-capitalized biopharmaceutical stocks which delivered poor returns over the long run. 18 blockbuster
The FDA advised to Pfizer, Moderna and Novavax to manufacture single-strain jabs targeting the omicron subvariant XBB.1.5 should prove to be a victory for some biotech ETFs.
Launched on 06/23/2005, the Invesco Dynamic Pharmaceuticals ETF (PJP) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Pharma segment of the equity
Many pharmaceutical companies have become highly dependent on a small number of drugs, if not one flagship drug. At the same time, the prescription pharmaceutical industry has become complicated, requ

Pharma ETFs Gain Post Q1 Earnings

01:01pm, Tuesday, 09'th May 2023
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. As such, pharma ETFs have been in the green over the past month.
The Invesco Dynamic Pharmaceuticals ETF (PJP) made its debut on 06/23/2005, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.
Sector ETF report for PJP
Smart Beta ETF report for PJP
Sector ETF report for PJP

Can Health Care Stocks Outperform Again In 2023?

06:09pm, Wednesday, 11'th Jan 2023
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
The debut highlights the lack of funds focused on the area.
Amgen (AMGN) has agreed to buy Horizon Therapeutics PLC (HZNP) for $27.8 billion. This put the spotlight on pharma ETFs, which could be the best way for investors to tap the opportunity arising from t
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE